James R. Neal
Net Worth

Last updated:

What is James R. Neal net worth?

The estimated net worth of Mr. James R. Neal is at least $30,156,992 as of 15 Jul 2022. He owns shares worth $1,115,227 as insider, has earned $13,448,005 from insider trading and has received compensation worth at least $15,593,760 in companies like XOMA Corporation, XOMA Corporation, XOMA Corporation etc.

What is the salary of James R. Neal?

Mr. James R. Neal salary is $742,560 per year as Chief Executive Officer & Chairman in XOMA Corporation. He also receives $742,560 as Chief Executive Officer & Chairman in XOMA Corporation and salaries from other companies.

How old is James R. Neal?

Mr. James R. Neal is 69 years old, born in 1956.

What stocks does James R. Neal currently own?

As insider, Mr. James R. Neal owns shares in 3 companies:

Company Title Shares Price per share Total value
XOMA Corporation (XOMA) Chief Executive Officer & Chairman 15,939 $32.06 $511,004
XOMA Corporation (XOMAP) Chief Executive Officer & Chairman 11,822 $25.71 $303,944
XOMA Corporation (XOMAO) Chief Executive Officer & Chairman 11,822 $25.4 $300,279

What does XOMA Corporation do?

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

XOMA logo
XOMA
XOMA Corporation
$32.06

What does XOMA Corporation do?

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

XOMAP logo
XOMAP
XOMA Corporation
$25.71

What does XOMA Corporation do?

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

XOMAO logo
XOMAO
XOMA Corporation
$25.4

James R. Neal insider trading

XOMA Corporation

Mr. James R. Neal has made 33 insider trades between 2014-2022, according to the Form 4 filled with the SEC. Most recently he sold 20,883 units of XOMA stock worth $617,093 on 15 Jul 2022.

The largest trade he's ever made was exercising 50,000 units of XOMA stock on 21 Mar 2022. As of 15 Jul 2022 he still owns at least 15,939 units of XOMA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 20,883 $29.55 $617,093
Option
Stock Option (Right to Buy) 25,000 N/A N/A
Option
Common Stock 1,111 $4.03 $4,477
Sale
Common Stock 1,111 $30.02 $33,348
Option
Stock Option (Right to Buy) 50,000 $4.03 $201,500
Option
Stock Option (Right to Buy) 1,111 $4.03 $4,477
Option
Stock Option (Right to Buy) 2,339 $4.03 $9,426
Option
Common Stock 2,339 $4.03 $9,426
Sale
Common Stock 2,339 $30.02 $70,210
Sale
Common Stock 50,000 $29.01 $1,450,250
Option
Common Stock 50,000 $4.03 $201,500
Sale
Common Shares 1,171 $34.3 $40,170
Sale
Common Shares 686 $35.13 $24,101
Sale
Common Shares 7,170 $33.36 $239,191
Sale
Common Stock 26,000 $20.58 $534,950
Option
Stock Option (Right to Buy) 26,000 N/A N/A
Option
Common Stock 26,000 $5.5 $143,000
Sale
Common Stock 26,000 $41.6 $1,081,522
Option
Stock Option (Right to Buy) 13,126 $32.96 $432,659
Sale
Common Stock 13,126 $32.96 $432,659
Option
Common Stock 13,126 $32.96 $432,659
Sale
Common Stock 6,874 $32.91 $226,203
Option
Common Stock 6,874 N/A N/A
Sale
Common Stock 6,874 $32.91 $226,203
Option
Stock Option (Right to Buy) 6,874 N/A N/A
Option
Stock Option (Right to Buy) 10,000 $5.5 $55,000
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 $26.7 $267,020
Purchase
Common Shares 1,000 N/A N/A
Purchase
Common Shares 1,000 N/A N/A
Sale
Common Stock 4,348 N/A N/A
Option
Stock Option (Right to Buy) 4,348 N/A N/A
Option
Common Stock 4,348 N/A N/A
Option
Stock Option (right to buy) 5,452 N/A N/A
Sale
Common Stock 5,452 N/A N/A
Option
Common Stock 5,452 N/A N/A
Sale
Common Stock 6,370 N/A N/A
Option
Stock Option (right to buy) 6,370 N/A N/A
Option
Common Stock 6,370 N/A N/A
Sale
Common Stock 3,830 N/A N/A
Option
Common Stock 3,830 N/A N/A
Option
Stock Option (right to buy) 3,830 N/A N/A
Purchase
Common Shares 4,000 N/A N/A
Sale
Common Shares 15,655 N/A N/A
Option
Common Shares 15,655 N/A N/A
Option
Non-Qualified Share Option (right to buy) 15,655 N/A N/A
Option
Common Shares 8,345 N/A N/A
Option
Non-Qualified Share Option (right to buy) 8,345 N/A N/A
Sale
Common Shares 8,345 N/A N/A
Option
Common Shares 26,145 N/A N/A
Option
Non-Qualified Share Option (right to buy) 26,145 N/A N/A
Sale
Common Shares 26,145 N/A N/A
Option
Common Shares 8,583 N/A N/A
Option
Non-Qualified Share Option (right to buy) 8,583 N/A N/A
Sale
Common Shares 8,583 N/A N/A
Sale
Common Shares 11,568 N/A N/A
Option
Non-Qualified Share Option (right to buy) 11,568 N/A N/A
Option
Common Shares 11,568 N/A N/A
Sale
Common Shares 5,105 N/A N/A
Sale
Common Shares 195 N/A N/A
Sale
Common Shares 125 N/A N/A
Sale
Common Shares 150 N/A N/A
Sale
Common Shares 2,500 N/A N/A
Sale
Common Shares 19,813 N/A N/A
Sale
Common Shares 1,678 N/A N/A
Sale
Common Shares 1,032 N/A N/A
Sale
Common Shares 4,387 N/A N/A
Sale
Common Shares 6,584 N/A N/A
Sale
Common Shares 2,671 N/A N/A

XOMA Corporation

Mr. James R. Neal has made 11 insider trades between 2020-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 50,000 units of XOMAP stock on 21 Mar 2022. As of 15 Jul 2022 he still owns at least 11,822 units of XOMAP stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 25,000 $4.03 $100,750
Sale
Common Stock 20,883 $29.55 $617,093
Sale
Common Stock 3,212 $31.19 $100,176
Sale
Common Stock 905 $31.86 $28,834
Option
Common Stock 25,000 $4.03 $100,750
Option
Stock Option (Right to Buy) 1,111 $4.03 $4,477
Sale
Common Stock 1,111 $30.02 $33,348
Option
Stock Option (Right to Buy) 50,000 $4.03 $201,500
Option
Common Stock 1,111 $4.03 $4,477
Option
Stock Option (Right to Buy) 2,339 $4.03 $9,426
Option
Common Stock 2,339 $4.03 $9,426
Sale
Common Stock 2,339 $30.02 $70,210
Option
Common Stock 50,000 $4.03 $201,500
Sale
Common Stock 50,000 $29.01 $1,450,250
Sale
Common Shares 9,027 $34.27 $309,319
Sale
Common Stock 26,000 $41.6 $1,081,522
Option
Common Stock 26,000 $5.5 $143,000
Option
Stock Option (Right to Buy) 26,000 $5.5 $143,000
Option
Common Stock 13,126 $32.96 $432,659
Option
Stock Option (Right to Buy) 13,126 $32.96 $432,659
Sale
Common Stock 13,126 $32.96 $432,659
Option
Stock Option (Right to Buy) 6,874 $5.5 $37,807
Option
Common Stock 6,874 $5.5 $37,807
Sale
Common Stock 6,874 $32.91 $226,203
Option
Stock Option (Right to Buy) 10,000 $5.5 $55,000
Option
Common Stock 10,000 $5.5 $55,000
Sale
Common Stock 10,000 $26.7 $267,020

XOMA Corporation

Mr. James R. Neal has made 11 insider trades between 2020-2022, according to the Form 4 filled with the SEC. Most recently he sold 1,111 units of XOMAO stock worth $33,348 on 23 Mar 2022.

The largest trade he's ever made was exercising 50,000 units of XOMAO stock on 21 Mar 2022. As of 15 Jul 2022 he still owns at least 11,822 units of XOMAO stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,111 $30.02 $33,348
Option
Common Stock 1,111 $4.03 $4,477
Option
Stock Option (Right to Buy) 50,000 $4.03 $201,500
Option
Stock Option (Right to Buy) 2,339 $4.03 $9,426
Option
Stock Option (Right to Buy) 1,111 $4.03 $4,477
Sale
Common Stock 2,339 $30.02 $70,210
Option
Common Stock 2,339 $4.03 $9,426
Option
Common Stock 50,000 $4.03 $201,500
Sale
Common Stock 50,000 $29.01 $1,450,250
Sale
Common Shares 686 $35.13 $24,101
Sale
Common Shares 1,171 $34.3 $40,170
Sale
Common Shares 7,170 $33.36 $239,191
Sale
Common Stock 20,294 $41.15 $835,098
Option
Common Stock 26,000 $5.5 $143,000
Sale
Common Stock 5,706 $42.04 $239,903
Option
Stock Option (Right to Buy) 26,000 $5.5 $143,000
Sale
Common Stock 13,126 $32.96 $432,659
Option
Stock Option (Right to Buy) 13,126 $5.5 $72,193
Option
Stock Option (Right to Buy) 6,874 $5.5 $37,807
Option
Common Stock 13,126 $5.5 $72,193
Sale
Common Stock 6,448 $32.46 $209,315
Sale
Common Stock 426 $33.35 $14,208
Option
Common Stock 6,874 $5.5 $37,807

XOMA key executives

XOMA Corporation executives and other stock owners filed with the SEC: